ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,307.01
-0.27%
Dow Jones
39,671.04
-0.51%
US Dollar vs MXN
16.65001
-0.09%
Brent Oil
82.305
0.95%
Bitcoin
69,674.01
0.83%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Gritstone bio Inc (GRTS)

  7. Gritstone bio Inc (GRTS) Noticias

GRTS

Gritstone bio (GRTS)

Gritstone bio Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GRTS
FechaHoraFuenteTítuloSímboloCompañía
17/05/202420:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRTSGritstone bio Inc
10/05/202415:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GRTSGritstone bio Inc
09/05/202415:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRTSGritstone bio Inc
09/05/202415:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTSGritstone bio Inc
09/05/202415:05GlobeNewswire Inc.Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:GRTSGritstone bio Inc
02/05/202415:05GlobeNewswire Inc.Gritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024NASDAQ:GRTSGritstone bio Inc
30/04/202406:00GlobeNewswire Inc.Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024NASDAQ:GRTSGritstone bio Inc
29/04/202406:00GlobeNewswire Inc.Gritstone bio Announces Appointment of Stephen Webster to its Board of DirectorsNASDAQ:GRTSGritstone bio Inc
15/04/202406:00GlobeNewswire Inc.Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)NASDAQ:GRTSGritstone bio Inc
08/04/202407:00GlobeNewswire Inc.Gritstone bio to Participate in Upcoming Investor and Scientific ConferencesNASDAQ:GRTSGritstone bio Inc
08/04/202406:00GlobeNewswire Inc.Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024NASDAQ:GRTSGritstone bio Inc
01/04/202422:00GlobeNewswire Inc.Gritstone bio Announces Pricing of $32.5 Million Underwritten Public OfferingNASDAQ:GRTSGritstone bio Inc
01/04/202415:10GlobeNewswire Inc.Gritstone bio Announces Proposed Public OfferingNASDAQ:GRTSGritstone bio Inc
01/04/202415:01GlobeNewswire Inc.Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite StaNASDAQ:GRTSGritstone bio Inc
05/03/202415:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GRTSGritstone bio Inc
05/03/202415:05GlobeNewswire Inc.Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:GRTSGritstone bio Inc
29/02/202415:05GlobeNewswire Inc.Gritstone bio Announces Workforce Reduction NASDAQ:GRTSGritstone bio Inc
13/02/202411:44Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRTSGritstone bio Inc
12/02/202406:00GlobeNewswire Inc.Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical TrialNASDAQ:GRTSGritstone bio Inc
08/02/202415:30GlobeNewswire Inc.Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GRTSGritstone bio Inc
17/01/202406:00GlobeNewswire Inc.Gritstone bio to Participate in Upcoming Investor ConferenceNASDAQ:GRTSGritstone bio Inc
01/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GRTSGritstone bio Inc
22/12/202315:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GRTSGritstone bio Inc
20/11/202306:00GlobeNewswire Inc.Gritstone bio to Participate in Upcoming Investor ConferencesNASDAQ:GRTSGritstone bio Inc
08/11/202315:05GlobeNewswire Inc.Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:GRTSGritstone bio Inc
12/10/202316:00GlobeNewswire Inc.Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA AwardNASDAQ:GRTSGritstone bio Inc
11/10/202306:10GlobeNewswire Inc.Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 VaccineNASDAQ:GRTSGritstone bio Inc
04/10/202315:05GlobeNewswire Inc.Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023NASDAQ:GRTSGritstone bio Inc
27/09/202315:01GlobeNewswire Inc.Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 MillionNASDAQ:GRTSGritstone bio Inc
15/08/202306:00GlobeNewswire Inc.Gritstone bio and Genevant Sciences Announce Option and License AgreementNASDAQ:GRTSGritstone bio Inc
 Showing the most relevant articles for your search:NASDAQ:GRTS

Su Consulta Reciente

UNSW
LUAETH
LuaToken
NASDAQ
AAYRFXX
Royal Bank of Canada Itm...
BOV
TRPL3F
ISA CTEEP ON
LSE
BAY
Bay Capital
TSXV
GUN
Gunpoint Exploration
BIT
SRIC
BNP Paribas Easy EUR Cor...
LSE
0GGS
Matra Petroleum Ab
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados